-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial
Changhoon Yoo & Yoon-Koo Kang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Corrigendum
Corrigendum: Clinical Investigation
-
Corrigendum
Corrigendum: Clinical Investigation
-
Corrigendum
Corrigendum: Clinical Investigation
-
Corrigendum
Corrigendum: Clinical Investigation
-
Corrigendum
Corrigendum: Clinical Investigation
-
Corrigendum
Corrigendum: Clinical Investigation
-
Corrigendum
Corrigendum: Clinical Investigation
-
Corrigendum
Corrigendum: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 7
Acknowledgements: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
New evidence supports tandem treatment in some ovarian cancers
News and Views: Clinical Investigation
-
Beyond Jadad: some essential features in trial quality
Sunny Y Alperson ,Vance W Berger
Perspective: Clinical Investigation
-
Beyond Jadad: some essential features in trial quality
Sunny Y Alperson ,Vance W Berger
Perspective: Clinical Investigation
-
Beyond Jadad: some essential features in trial quality
Sunny Y Alperson ,Vance W Berger
Perspective: Clinical Investigation
-
Beyond Jadad: some essential features in trial quality
Sunny Y Alperson ,Vance W Berger
Perspective: Clinical Investigation
-
Beyond Jadad: some essential features in trial quality
Sunny Y Alperson ,Vance W Berger
Perspective: Clinical Investigation
-
Beyond Jadad: some essential features in trial quality
Sunny Y Alperson ,Vance W Berger
Perspective: Clinical Investigation
-
Beyond Jadad: some essential features in trial quality
Sunny Y Alperson ,Vance W Berger
Perspective: Clinical Investigation
-
Beyond Jadad: some essential features in trial quality
Sunny Y Alperson ,Vance W Berger
Perspective: Clinical Investigation
-
Emerging treatments for small-cell lung cancer: Phase II and III trials
Joel W Neal, Matthew A Gubens, Heather A Wakelee
Review Article: Clinical Investigation
-
Emerging treatments for small-cell lung cancer: Phase II and III trials
Joel W Neal, Matthew A Gubens, Heather A Wakelee
Review Article: Clinical Investigation
-
Emerging treatments for small-cell lung cancer: Phase II and III trials
Joel W Neal, Matthew A Gubens, Heather A Wakelee
Review Article: Clinical Investigation
-
Emerging treatments for small-cell lung cancer: Phase II and III trials
Joel W Neal, Matthew A Gubens, Heather A Wakelee
Review Article: Clinical Investigation
-
Emerging treatments for small-cell lung cancer: Phase II and III trials
Joel W Neal, Matthew A Gubens, Heather A Wakelee
Review Article: Clinical Investigation
-
Emerging treatments for small-cell lung cancer: Phase II and III trials
Joel W Neal, Matthew A Gubens, Heather A Wakelee
Review Article: Clinical Investigation
-
Emerging treatments for small-cell lung cancer: Phase II and III trials
Joel W Neal, Matthew A Gubens, Heather A Wakelee
Review Article: Clinical Investigation
-
Emerging treatments for small-cell lung cancer: Phase II and III trials
Joel W Neal, Matthew A Gubens, Heather A Wakelee
Review Article: Clinical Investigation